Why is Shree Ganesh Bio falling/rising?

As of 17-Sep, Shree Ganesh Biotech India Ltd's stock price is flat at 0.79, with no change in percentage terms. The stock has underperformed its sector by 0.85% today, and while it is higher than the 20-day moving average, it is lower than the 5-day, 50-day, 100-day, and 200-day moving averages. The delivery volume has decreased by 1.31% compared to the 5-day average, indicating falling investor participation. Over the past year, the stock has seen a significant decline of 28.83%, with operating losses and a weak ability to service its debt reflected in a poor EBIT to Interest ratio of 0.97. The company's low profitability, with an average Return on Equity of 2.52%, further contributes to its weak long-term fundamental strength.
In the broader market context, the stock's short-term performance shows a 1.28% increase over the past month, which is less than the Sensex's 2.60% increase during the same period. Year-to-date, the stock has declined by 24.04%, contrasting sharply with the Sensex's positive return of 5.83%. The significant underperformance over various time frames, including a staggering 85.05% drop over the past five years compared to the Sensex's 112.14% gain, highlights the challenges faced by Shree Ganesh Biotech India Ltd in a market that is generally moving upward.